These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 39062885)

  • 1. Comparative Analysis of Mitochondria Surrounding the Intercalated Discs in Heart Diseases-An Ultrastructural Pilot Study.
    Schönmehl R; Mendelsohn DH; Winter L; Pabel S; Niedermair T; Evert K; Cheung WH; Wong RMY; Schmitt VH; Keller K; Barsch F; Dietl A; Gummert JF; Schramm R; Sossalla S; Brochhausen C
    Int J Mol Sci; 2024 Jul; 25(14):. PubMed ID: 39062885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heart mitochondrial proteome study elucidates changes in cardiac energy metabolism and antioxidant PRDX3 in human dilated cardiomyopathy.
    Roselló-Lletí E; Tarazón E; Barderas MG; Ortega A; Otero M; Molina-Navarro MM; Lago F; González-Juanatey JR; Salvador A; Portolés M; Rivera M
    PLoS One; 2014; 9(11):e112971. PubMed ID: 25397948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative 3D electron microscopy characterization of mitochondrial structure, mitophagy, and organelle interactions in murine atrial fibrillation.
    Guttipatti P; Saadallah N; Ji R; Avula UMR; Goulbourne CN; Wan EY
    J Struct Biol; 2024 Sep; 216(3):108110. PubMed ID: 39009246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional networks of nucleocytoplasmic transport-related genes differentiate ischemic and dilated cardiomyopathies. A new therapeutic opportunity.
    Molina-Navarro MM; Triviño JC; Martínez-Dolz L; Lago F; González-Juanatey JR; Portolés M; Rivera M
    PLoS One; 2014; 9(8):e104709. PubMed ID: 25137373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of inwardly rectifying K+ channel in human cardiac myocytes. Alterations in channel behavior in myocytes isolated from patients with idiopathic dilated cardiomyopathy.
    Koumi S; Backer CL; Arentzen CE
    Circulation; 1995 Jul; 92(2):164-74. PubMed ID: 7600647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of left ventricular assist device therapy on the cardiac proteome and metabolome composition in ischemic cardiomyopathy.
    Shahinian JH; Rog-Zielinska EA; Schlimpert M; Mayer B; Tholen S; Kammerer B; Biniossek ML; Beyersdorf F; Schilling O; Siepe M
    Artif Organs; 2020 Mar; 44(3):257-267. PubMed ID: 31494943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intercalated disc in failing hearts from patients with dilated cardiomyopathy: Its role in the depressed left ventricular function.
    Ortega A; Tarazón E; Gil-Cayuela C; García-Manzanares M; Martínez-Dolz L; Lago F; González-Juanatey JR; Cinca J; Jorge E; Portolés M; Roselló-Lletí E; Rivera M
    PLoS One; 2017; 12(9):e0185062. PubMed ID: 28934278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of surgical ventricular reconstruction and mitral complex reconstruction on cardiac oxidative metabolism and efficiency in nonischemic and ischemic dilated cardiomyopathy.
    Sugiki T; Naya M; Manabe O; Wakasa S; Kubota S; Chiba S; Iwano H; Yamada S; Yoshinaga K; Tamaki N; Tsutsui H; Matsui Y
    JACC Cardiovasc Imaging; 2011 Jul; 4(7):762-70. PubMed ID: 21757167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knockdown of cytochrome P450 2E1 inhibits oxidative stress and apoptosis in the cTnT(R141W) dilated cardiomyopathy transgenic mice.
    Lu D; Ma Y; Zhang W; Bao D; Dong W; Lian H; Huang L; Zhang L
    Hypertension; 2012 Jul; 60(1):81-9. PubMed ID: 22665122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of cardiac transplantation on molecular pathology of ET-1, VEGF-C, and mitochondrial metabolism and morphology in dilated versus ischemic cardiomyopathic patients.
    Aharinejad S; Schäfer R; Hofbauer R; Abraham D; Blumer R; Miksovsky A; Traxler H; Pullirsch D; Alexandrowicz R; Taghavi S; Kocher A; Laufer G
    Transplantation; 2001 Sep; 72(6):1043-9. PubMed ID: 11579298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regional mapping of myocardial hibernation phenotype in idiopathic end-stage dilated cardiomyopathy.
    Lionetti V; Matteucci M; Ribezzo M; Di Silvestre D; Brambilla F; Agostini S; Mauri P; Padeletti L; Pingitore A; Delsedime L; Rinaldi M; Recchia FA; Pucci A
    J Cell Mol Med; 2014 Mar; 18(3):396-414. PubMed ID: 24444256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RNA sequencing analysis and atrial natriuretic peptide production in patients with dilated and ischemic cardiomyopathy.
    Tarazón E; Roselló-Lletí E; Rivera M; Ortega A; Molina-Navarro MM; Triviño JC; Lago F; González-Juanatey JR; Orosa P; Montero JA; Salvador A; Portolés M
    PLoS One; 2014; 9(3):e90157. PubMed ID: 24599027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of atrial fibrillation in dilated cardiomyopathy.
    Takarada A; Kurogane H; Hayashi T; Fujimoto T; Yasaka Y; Fukumoto Y; Shimatani Y; Yamakawa H; Sasaki S; Matsuura A
    Jpn Heart J; 1993 Nov; 34(6):749-58. PubMed ID: 8164342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apoptosis in heart failure: release of cytochrome c from mitochondria and activation of caspase-3 in human cardiomyopathy.
    Narula J; Pandey P; Arbustini E; Haider N; Narula N; Kolodgie FD; Dal Bello B; Semigran MJ; Bielsa-Masdeu A; Dec GW; Israels S; Ballester M; Virmani R; Saxena S; Kharbanda S
    Proc Natl Acad Sci U S A; 1999 Jul; 96(14):8144-9. PubMed ID: 10393962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The end-stage failing human myocardium - Where changes in ultrastructure of human cardiac muscle cells do not appear to dictate clinical outcomes.
    Varga I; Galfiova P; Gazova A; Barczi T; Polak S; Danisovic L; Hulman M; Kyselovic J
    Med Hypotheses; 2018 Jan; 110():105-109. PubMed ID: 29317051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atrial high energy phosphate content and mitochondrial enzyme activity during chronic atrial fibrillation.
    Ausma J; Coumans WA; Duimel H; Van der Vusse GJ; Allessie MA; Borgers M
    Cardiovasc Res; 2000 Sep; 47(4):788-96. PubMed ID: 10974227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sarcoplasmic reticulum Ca2+ATPase and phospholamban mRNA and protein levels in end-stage heart failure due to ischemic or dilated cardiomyopathy.
    Flesch M; Schwinger RH; Schnabel P; Schiffer F; van Gelder I; Bavendiek U; Südkamp M; Kuhn-Regnier F; Böhm M
    J Mol Med (Berl); 1996 Jun; 74(6):321-32. PubMed ID: 8862513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regional heterogeneity of decreased myocardial norepinephrine and increased lipid peroxidation levels in patients with end-stage failing heart secondary to dilated or ischemic cardiomyopathy.
    Rochette L; Tatou E; Vergely C; Maupoil V; Bouchot O; Mossiat C; Jazayeri S; Benkhadra S; Brenot R; Girard C; David M
    J Heart Lung Transplant; 2008 Jul; 27(7):767-74. PubMed ID: 18582807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Left-ventricular expression of interleukin-6 messenger-RNA higher in idiopathic dilated than in ischemic cardiomyopathy.
    Plenz G; Song ZF; Reichenberg S; Tjan TD; Robenek H; Deng MC
    Thorac Cardiovasc Surg; 1998 Aug; 46(4):213-6. PubMed ID: 9776495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regional absence of mitochondria causing energy depletion in the myocardium of muscle LIM protein knockout mice.
    van den Bosch BJ; van den Burg CM; Schoonderwoerd K; Lindsey PJ; Scholte HR; de Coo RF; van Rooij E; Rockman HA; Doevendans PA; Smeets HJ
    Cardiovasc Res; 2005 Feb; 65(2):411-8. PubMed ID: 15639480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.